ArticlesColliers: The number of residential properties sold in Bucharest in the first quarter of 2024 was 18% higher than in the same period last…
ArticleseJobs survey: 7 out of 10 employers will offer employees benefits during the Easter holidays. Cash bonuses, gift vouchers and baskets with seasonal products…
ArticleseJobs x Up Romania survey: 41% of employees are dissatisfied and very dissatisfied with their current job
ArticlesBCR Leasing offers microenterprises and PFA clients 100% digital access to active financing contracts, directly in the George ecosystem
ArticlesExtended update for Mercedes-Benz EQS
InterviewsHow do we evaluate shares in 2024? Opportunities vs. risks
InterviewsEmpowering your digital journey with SoftwareOne, globally and locally. Turn vision into reality with a valuable recipe
InterviewsNoventiq: Unlocking Romania's Digital Potential
InterviewsStrauss Romania: Evolving the consumers coffee experience is crucial
InterviewsA long term partnership is better than the commercial value of a deal
NewsOrange announces a new portfolio with fiber and TV subscriptions with 4 simplified packages, at affordable prices and Netflix included
News25 years of DENT ESTET in Romania - Investments of tens of millions of euros in the medical infrastructure and hundreds of thousands of…
NewsIrina Peptine is the new Marketing Director of Schneider Electric Romania, Moldova and Armenia
NewsBusiness Evolution, the road show on "Financing. Digitization. Efficient management", arrives for the first time in Suceava on 24 April 2024
NewsFAST FORWARD. THE ORGANIZATION OF THE FUTURE - 20th EDITION

Mylan completed the acquisition of mature and generic drugs division of Abbott Company

DOINGBUSINESS.RO SRL

2 Mar 2015

Mylan N.V. and Mylan Inc. ( Nasdaq: MYL ) announced on February 27, 2015 the successful completion of the take-over of mature and generic drugs division of Abbott Laboratories (NYSE : ABT ) in developed markets outside the United States .

As a result of this transaction, Abbott received 110 million shares of Mylan NV , representing 22% of total shares, the remaining 78 % being held by the previous shareholders of Mylan Inc. , the current company Mylan NV.

For more information, please see the Romanian version of the article, here.

Authors

foto

DOINGBUSINESS.RO SRL

Multimedia business information provider; Company database provider.

See all published materials

View company profile

Tags : medicamente

© 2024, DoingBusiness.ro